Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

Sapio Sciences today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By deploying Sapio’s unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows.

ActiGraph and Hyfe announce availability of new digital health tool for cough monitoring

ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.

The MAP Group Unites Three Companies Under One New Brand Name, Kintiga

The MAP Group unifies under new brand name

Endor Labs Empowers Organizations to Discover and Govern Open Source Artificial Intelligence Models Used in Applications

Endor Labs, the leader in open source software security, today announced a brand new feature in the company’s signature platform enabling organizations to discover the AI models already in use across their applications, and to set and enforce security policies over which models are permitted. Endor Labs AI Model Discovery directly addresses three critical use cases: It enables application security professionals to discover local open source AI models being used in their application code; evaluate risks from those models; and enforce organization-wide policies related to AI model curation and usage. It even goes a step further with automated detection, warning.

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences

Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences.

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Ambience Healthcare Joins athenahealth’s Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination

DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration

DNAnexus and Veeva announced an agreement to help advance global regulatory collaboration. The integrated solution will allow users to establish secure collaboration zones with international agencies to share data for regulatory review, validation, and analysis.

Cellular Origins and Cytiva are collaborating to deliver automated robotic manufacturing capabilities for cell and gene therapies

Avalon Healthcare Solutions to Team with Sentara Health Plans to Offer Genetic Testing Management

Avalon Healthcare Solutions to Team with Sentara Health Plans to Offer Genetic Testing Management

Ambience Healthcare and St. Luke's Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

Ambience Healthcare, the leading AI platform for healthcare documentation, scribing, coding, CDI, and patient summaries, announced today a pilot study with St. Luke's Health System has resulted in a 25% reduction in clinician burnout and a nearly 23% increase in patient face time for clinicians.

Cotiviti Launches Engagement Hub Solution to Empower Health Plans to Drive Member Outreach

University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx

DoseMe, a leader in model-informed precision dosing (MIPD), announced the University Medical Centre Ljubljana and University Hospital of Maribor have implemented DoseMeRx, an innovative therapeutic drug monitoring (TDM) platform. This marks a significant advancement in antimicrobial stewardship in Slovenia.

Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology

Record year comes as the rise of precision medicine drives a surge in demand

Integrated DNA Technologies Names Ajay Gannerkote as New President to Lead Bold Era of Innovation and Growth

Ajay Gannerkote, an experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation, takes helm at global genomics company

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics

Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio’s proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy.

Coronado Research announce appointment of Jo Marshall as EVP Data Services and Advanced Analytics

Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.

STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance

STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.

Kindeva Drug Delivery and Emervax Partner To Bring Game Changing Vaccine Administration to Patients